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Growth of new dendritic spines contributes to
experience-dependent circuit plasticity in the cere-
bral cortex. Yet the signaling mechanisms leading
to new spine outgrowth remain poorly defined.
Increasing evidence supports that the proteasome
is an important mediator of activity-dependent
neuronal signaling. We therefore tested the role of
the proteasome in activity-dependent spinogenesis.
Using pharmacological manipulations, glutamate un-
caging, and two-photon imaging of GFP-transfected
hippocampal pyramidal neurons, we demonstrate
that acute inhibition of the proteasome blocks
activity-induced spine outgrowth. Remarkably,
mutation of serine 120 to alanine of the Rpt6 protea-
somal subunit in individual neurons was sufficient to
block activity-induced spine outgrowth. Signaling
through NMDA receptors and CaMKII, but not PKA,
is required to facilitate spine outgrowth. Moreover,
abrogating CaMKII binding to the NMDA receptor
abolished activity-induced spinogenesis. Our data
support a model in which neural activity facilitates
spine outgrowth via an NMDA receptor- and CaM-
KII-dependent increase in local proteasomal degra-
dation.
INTRODUCTION
Rapid and stable modification of neural circuits is thought to
underlie learning and memory. The signaling pathways that
mediate this circuit plasticity are thought to drive both functional
and structural changes in existing synapses, as well as the addi-
tion of new synapses. In the mammalian cerebral cortex, the
addition of new synapses during experience-dependent plas-
ticity has been associated with the addition of dendritic spines
(Comery et al., 1995; Knott et al., 2002; Trachtenberg et al.,
2002). Moreover, the appearance of new persistent spines has
been associated with novel sensory experience and learning
new tasks (Hofer et al., 2009; Holtmaat et al., 2006; Robertset al., 2010; Xu et al., 2009; Yang et al., 2009). While new
dendritic spines tend to be short lived (Trachtenberg et al.,
2002), those that stabilize are capable of rapid functional matu-
ration (Zito et al., 2009). These data support that the formation
and stabilization of new dendritic spines is a key structural
component underlying synaptic plasticity.
Although the detailed signaling mechanisms that initiate the
outgrowth of new dendritic spines during experience-depen-
dent plasticity remain poorly defined, there is strong evidence
that increased neural activity can enhance new spine growth
(Engert and Bonhoeffer, 1999; Kwon and Sabatini, 2011;
Maletic-Savatic et al., 1999; Papa and Segal, 1996). Multiple
studies demonstrate that activity-induced spine outgrowth is
dependent on NMDA receptor signaling (Engert and Bonhoeffer,
1999; Kwon and Sabatini, 2011; Maletic-Savatic et al., 1999).
What further signaling mechanisms act downstream of activity
to initiate new spine growth? Over the past decade, evidence
has been rapidly accumulating that the proteasome is an
important mediator of activity-induced neuronal signaling (Bin-
gol and Sheng, 2011; Tai and Schuman, 2008). Neural activity
regulates proteasomal activity (Bingol and Schuman, 2006;
Djakovic et al., 2009), resulting in alterations in the abundance
of synaptic proteins (Ehlers, 2003). Moreover, activity-depen-
dent changes in the rate of proteasome-mediated degradation
can occur rapidly and can be localized to a small region of the
stimulated dendrite (Bingol and Schuman, 2006; Djakovic
et al., 2009). These data suggest that the proteasome is a key
downstream mediator of localized activity-dependent neuronal
signaling and therefore may play a role in activity-dependent
spinogenesis.
In this study, we used pharmacological and genetic manipula-
tions in combination with time-lapse two-photon microscopy
and two-photon glutamate uncaging to investigate the role of
the proteasome in new spine growth on dendrites of hippo-
campal pyramidal neurons. We show that acute inhibition of
the proteasome rapidly reduces the rate of spine outgrowth.
Synaptic activity, NMDA receptors, and CaMKII, but not
PKA, are upstream regulators of proteasome-mediated spine
outgrowth, which is dependent upon interaction between
CaMKII and the GluN2B subunit of the NMDA receptor. The
S120 residue of the Rpt6 proteasomal subunit is critical for
proteasome-dependent spine outgrowth in individual neurons,
indicating that the proteasome acts postsynaptically and in aNeuron 74, 1023–1030, June 21, 2012 ª2012 Elsevier Inc. 1023
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Figure 1. Acute Inhibition of the Protea-
some Rapidly Decreases New Spine Growth
(A) Images of dendrites from EGFP-expressing
neurons at 7–12 DIV before and after the addition
of vehicle, MG132, or lactacystin at t = 0 (black
arrow). Yellow arrows indicate new spines. (B)
MG132 (10 mM) decreased the rate of spine
outgrowth (green bar; 34 spines, 5 cells) as
compared to vehicle control (black bar; 68 spines,
6 cells; p < 0.05). (C) Lactacystin (10 mM)
decreased the rate of spine outgrowth (light green
bar; 33 spines, 6 cells) as compared to vehicle
control (black bar; 131 spines, 8 cells; p < 0.01).
Doubling the concentration of lactacystin (20 mM)
inhibited spine outgrowth to a comparable extent
(dark green bar; 25 spines, 6 cells; p < 0.001). (D)
New spine growth was significantly reduced within
5 min after addition of lactacystin (10 mM) and
remained significantly reduced for all subsequent
time points (p < 0.05). Error bars represent SEM.
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Proteasomal Regulation of New Spine Growthcell-autonomous manner to regulate spine outgrowth. Our data
support a model in which synaptic activity promotes spine
outgrowth via an NMDA receptor- and CaMKII-mediated regula-
tion of local proteasomal degradation.
RESULTS
Proteasome Inhibition Acutely Reduces New Spine
Outgrowth
To determine whether the proteasome plays a role in regulating
the growth of new dendritic spines, we used pharmacological
manipulations and time-lapse two-photon microscopy to
measure the effect of acute inhibition of the proteasome on the
rate of spine outgrowth. Hippocampal pyramidal neurons in or-
ganotypic slice cultures were transfected with enhanced green
fluorescent protein (EGFP) and imaged using a two-photon
microscope. Dendrites of EGFP-expressing CA1 neurons were
imaged at 15 or 20 min intervals before and after treatment
with drugs or vehicle (Figure 1A).
Treatment with the proteasome inhibitor MG132 (10 mM)
reduced the rate of spine outgrowth to half (52% ± 12%) that
of vehicle-treated control cells (100% ± 13%; p < 0.05;
Figure 1B). Because MG132 inhibits the activity of calpains
as well as the proteasome, we confirmed our findings with
the proteasome-specific inhibitor lactacystin. Treatment with
lactacystin (10 mM) reduced the rate of spine outgrowth by
68% (32% ± 7%) as compared to vehicle control (100% ±
13%; p < 0.001; Figure 1C). Similar reductions in spine out-1024 Neuron 74, 1023–1030, June 21, 2012 ª2012 Elsevier Inc.growth were observed for both apical
and basal dendrites (see Figure S1A
available online). The reduction in spine
outgrowth due to lactacystin was not
significantly different than that due to
MG132 (p = 0.2), suggesting that re-
duced spine outgrowth in the presence
of MG132 is specifically due to inhibition
of the proteasome. To ensure that
the effect of proteasome inhibition wassaturated, we doubled the concentration of lactacystin in the
bath. Treatment with 20 mM lactacystin resulted in a 62%
reduction in new spine growth (38% ± 7%), which was not
significantly different than that observed in the presence of
10 mM lactacystin (p = 0.6; Figure 1C), suggesting that spine
outgrowth observed in the presence of lactacystin is protea-
some independent.
A variety of cellular processes, including the endocytosis
of transmembrane proteins, are dependent on proteolysis-
independent ubiquitination (Acconcia et al., 2009; Hicke, 2001).
It is conceivable that a drop in free ubiquitin levels caused by
proteasome inhibition (Schubert et al., 2000) could interfere
with new spine growth via a secondary effect on endocytosis.
We think that this is unlikely for two reasons. First, the reduction
in new spine growth in response to proteasomal inhibition was
very rapid; we observed a significant reduction in spine
outgrowth within 5 min of drug application (p < 0.05; Figure 1D).
Second, a reduction in endocytosis might be expected to cause
an increase in spine volume or density, as spine volume and
stability are tightly linked to glutamate receptor content (Hsieh
et al., 2006; Matsuzaki et al., 2004). Within the time course of
our experiments, we saw no change in spine volume or spine
density in response to MG132 treatment (data not shown). The
lack of change in spine density might appear inconsistent with
the significantly decreased rate of spine addition in response
to MG132; however, because most new spines are transient,
reduced new spine outgrowth is expected to be accompanied
by reduced spine loss, which we observed (Figure S1B).
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Figure 2. Synaptic Activity Promotes New
Spine Growth in a Proteasome- and NMDA
Receptor-Dependent Manner
(A) Images of dendrites from EGFP-expressing
neurons at 5–10 DIV before and after the addition
of vehicle or bicuculline (30 mM) at t = 0 (black
arrow). Yellow arrows indicate new spines. (B)
Elevated neural activity in response to bicuculline
increased the rate of new spine addition (blue bar;
116 spines, 6 cells) as compared to vehicle control
(black bar; 68 spines, 6 cells; p < 0.01). Inhibiting
the proteasome with MG132 blocked the bicu-
culline-induced increase in spine outgrowth and
decreased baseline new spine growth (light green
bar; 46 spines, 7 cells; p < 0.05) to a level similar to
that in the presence of MG132 alone (dark green
bar; data from Figure 1; p = 0.4). (C) Schematic of
uncaging-induced spine outgrowth. A new spine
(red arrow) was induced by focal photolysis of
MNI-caged glutamate (red dot) adjacent to
a section of dendrite devoid of spines. (D) Images
of dendrites from EGFP-expressing neurons at 7–8
DIV before and after focal photolysis of MNI-
glutamate (red dots) at t = 0 (black arrow). Red
arrows indicate new spines. (E) Uncaging-induced
spine outgrowth (blue bar; 16 successes out of 44
trials on 15 cells) was significantly reduced in the
presence of lactacystin (10 mM; green bar; 6
successes out of 40 trials on 12 cells; p < 0.05). (F)
Images of dendrites from EGFP-expressing
neurons at 7–11 DIV before and after the addition
of CPP (30 mM) or CPP + lactacystin (10 mM) at
t = 0 (black arrow). Yellow arrows indicate
new spines. (G) The rate of new spine addition
decreased in the presence of CPP (light green bar;
39 spines, 8 cells) as compared to vehicle control
(black bar; 105 spines, 8 cells; p < 0.001). No
further decrease in spine outgrowth was observed
with simultaneous blockade of the proteasome
with lactacystin (dark green bar; 45 spines, 7 cells;
p = 0.4). Error bars represent SEM.
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Proteasomal Regulation of New Spine GrowthOur data suggest that the reduction in new spine growth in
response to proteasome inhibitors is due to acute inhibition of
proteasomal activity.
Synaptic Activity Promotes New Spine Growth
in a Proteasome-Dependent Manner
Because synaptic activity can enhance both spine outgrowth
(Engert and Bonhoeffer, 1999; Kwon and Sabatini, 2011) and
the activity of the proteasome (Bingol and Schuman, 2006;
Djakovic et al., 2009), we next examined whether the protea-
some plays a role in regulating activity-induced spine outgrowth
(Figure 2). Treatment with bicuculline (30 mM), which strongly
enhanced synaptic activity (Figure S2), resulted in a 69%
increase in spine outgrowth (169% ± 16%) relative to vehicle-
treated controls (100% ± 13%; p < 0.05; Figures 2A and 2B).
The activity-induced increase in spine outgrowth was blocked
by concurrent application of MG132 (10 mM), which instead
caused a 34% decrease in spine outgrowth (66% ± 9%;
p < 0.05; Figure 2B), an effect that was indistinguishable from
treatment with MG132 alone (p = 0.4). Thus, we concludethat proteasomal degradation is necessary for activity-induced
spine outgrowth.
Because bicuculline alters global neural activity levels in our
slice cultures, we chose also to use a more localized dendritic
stimulus to examine the role of the proteasome in activity-
dependent spine outgrowth. A recent study using focal photol-
ysis of caged glutamate demonstrated that direct glutamatergic
stimulation of the dendrite can result in rapid spine outgrowth
(Kwon and Sabatini, 2011). Using two-photon uncaging of
MNI-glutamate and pharmacological inhibition, we examined
whether proteasomal degradation is necessary for glutamate
uncaging-induced spine outgrowth (Figures 2C and 2D). We
found that uncaging-induced spine outgrowth was significantly
reduced in the presence of lactacystin (15% success rate)
as compared to control (36% success rate; p < 0.05; Figure 2E).
This local activity-dependent spine outgrowth occurredwith high
spatial specificity such that most new spines (>87%) grew within
1 mmof the uncaging location. These results further demonstrate
that proteasomal degradation acts to facilitate activity-depen-
dent spine outgrowth in a spatially precise manner.Neuron 74, 1023–1030, June 21, 2012 ª2012 Elsevier Inc. 1025
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Figure 3. Mutation of Serine 120 to Alanine of the Rpt6 Proteasomal
Subunit Blocks Activity-Induced New Spine Growth
(A) Images of dendrites from hippocampal neurons transfected with EGFP,
EGFP + Rpt6-WT, or EGFP + Rpt6-S120A at 9–10 DIV before and after the
addition of vehicle or bicuculline at t = 0 (black arrow). Yellow arrows indicate
new spines. (B) Transfection with Rpt6-WT (gray bar; 121 spines, 7 cells;
p < 0.05) did not interfere with the bicuculline-induced increase in spine
outgrowth (blue bar; 149 spines, 8 cells; p < 0.05) relative to vehicle-treated
controls (black bar; 73 spines, 7 cells). In contrast, Rpt6-S120A transfection
reduced spine outgrowth in bicuculline-treated cells (green bar; 56 spines,
7 cells; p < 0.001) relative to vehicle-treated controls. (C) Transfection with
Rpt6-S120Adecreased the rate of spine outgrowth (gray bar; 32 spines, 6 cells)
as compared to cells transfectedwith EGFPalone (black bar; 74 spines, 6 cells;
p < 0.01). Treatment of Rpt6-S120A transfected neurons with lactacystin (light
green bar; 33 spines, 6 cells, p = 0.48) or with CPP (dark green bar; 44 spines,
7 cells, p = 0.24) did not further reduce rates of spine outgrowth over that
observed for untreated S120A transfected cells. Error bars represent SEM.
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1026 Neuron 74, 1023–1030, June 21, 2012 ª2012 Elsevier Inc.Signaling through the NMDA Receptor Is Required
for Proteasome-Dependent Dendritic Spine Outgrowth
Stimulation of proteasomal degradation by neural activity has
been shown to occur via the action of NMDA receptors (Bingol
and Schuman, 2006; Djakovic et al., 2009), which also have
been shown to play a role in activity-induced outgrowth of new
spines (Engert and Bonhoeffer, 1999; Kwon and Sabatini,
2011). Indeed, NMDA treatment increased the degradation of
a fluorescent proteasome substrate in dendrites of CA1 pyra-
midal neurons in our cultured hippocampal slices (Figure S3).
We therefore investigated the role of the NMDA receptor in pro-
teasome-dependent new spine growth (Figures 2F and 2G).
Inhibition of NMDA receptors with CPP (30 mM) resulted in
a 62% reduction in spine outgrowth (38% ± 5%) as compared
to vehicle control (100% ± 9%; p < 0.001; Figure 2G), suggesting
that baseline spine outgrowth is partially activity dependent. The
reduction in spine outgrowth observed after CPP treatment was
not different than that after lactacystin treatment (p = 0.3),
suggesting that the NMDA receptor and the proteasome act in
the same pathway to induce new spine growth. To test this
idea, we simultaneously applied lactacystin and CPP. Simulta-
neous treatment with both lactacystin and CPP resulted in
a 53% reduction in new spine growth (47% ± 9%) as compared
to vehicle control (100% ± 8%; p < 0.05; Figure 2G), a decrease
that was not different than that observed in response to CPP
(p = 0.7) or lactacystin (p = 0.3; Figure 1C) alone. Our data
demonstrate that the NMDA receptor and the proteasome act
in the same pathway to promote new spine growth in response
to neural activity.
Mutation of Serine 120 to Alanine in the Rpt6
Proteasomal Subunit Blocks Activity-Induced New
Spine Growth
Which signaling mechanisms act downstream of the NMDA
receptor and the proteasome to translate neural activity into
enhanced spine growth? Recent work has identified serine 120
of the Rpt6 proteasomal subunit as an important target site for
CaMKII phosphorylation (Bingol et al., 2010; Djakovic et al.,
2012). To test whether the S120 residue of Rpt6 is necessary
for activity-dependent spine outgrowth, we used time-lapse
imaging to monitor new spine growth on dendrites of neurons
transfected with EGFP alone or with both EGFP and hemagglu-
tinin (HA)-tagged Rpt6-WT or Rpt6-S120A (Figure 3A). Expres-
sion levels were equivalent for both of the HA-tagged Rpt6
constructs, as verified through retrospective immunostaining
(data not shown).
As expected, we found that spine outgrowth increased in
the presence of bicuculline for neurons transfected with EGFP
alone (166% ± 13%, p < 0.05) or with EGFP and Rpt6-WT
(161% ± 19%, p < 0.05) as compared to vehicle control
(100% ± 11%; Figure 3B). Remarkably, neurons transfected
with EGFP and Rpt6-S120A did not show a bicuculline-depen-
dent increase in new spine growth and instead showed a 44%
decrease in spine outgrowth (56% ± 8%; p < 0.05; Figure 3B),
a level indistinguishable from the 55% decrease in outgrowth
observed in vehicle-treated neurons expressing Rpt6-S120A
(45% ± 5%; p = 0.4; Figure 3C). Treatment of Rpt6-S120A
transfected cells with lactacystin did not further depress spine
Neuron
Proteasomal Regulation of New Spine Growthoutgrowth (50% ± 5%; Figure 3C) compared to vehicle-treated
Rpt6-S120A cells (p = 0.5), suggesting that the Rpt6-S120
residue is necessary for all proteasome-mediated spine
outgrowth. Furthermore, treatment of Rpt6-S120A transfected
cells with 30 mMCPP did not result in a further decrease in spine
outgrowth (54% ± 6%; Figure 3C) compared to untreated
Rpt6-S120A controls (p = 0.2), suggesting that the S120A
residue of Rpt6 is a key regulatory site for proteasome- and
NMDA receptor-dependent facilitation of new spine growth.
Inhibition of CaMKII, but Not PKA, Decreases the Rate
of New Spine Growth
Recent work has demonstrated that both PKA (Zhang et al.,
2007) and CaMKIIa (Djakovic et al., 2009) are capable of phos-
phorylating the Rpt6 subunit of the proteasome at serine 120.
In addition, CaMKIIa has been shown to mediate activity-depen-
dent recruitment of proteasomes to dendritic spines (Bingol
et al., 2010), and phosphorylation of Rpt6 by CaMKIIa increases
the rate of proteasomal degradation (Djakovic et al., 2012).
Finally, both CaMKII (Jourdain et al., 2003) and PKA (Kwon and
Sabatini, 2011) have been implicated in activity-dependent spine
outgrowth.We therefore chose to investigate the roles of CaMKII
and PKA in activity- and proteasome-dependent new spine
growth (Figures 4A and 4B).
Inhibition of CaMKII with KN-93 (30 mM), which inhibits Ca2+-
and CaM-dependent kinases, resulted in a 65% reduction in
new spine growth (35% ± 6%) as compared to vehicle control
(100% ± 11%; p < 0.001; Figure 4B). In contrast, the rate of
new spine outgrowth was not significantly different from vehicle
controls (100% ± 20%) when PKA was inhibited with either
myristoylated PKI 14–22 amide (5 mM; 104% ± 11%; p = 0.9;
Figure 4B) or Rp-cAMPS (20 mM; 120% ± 15%; p = 0.4;
Figure 4B). In order to examine whether CaMKII inhibition
might reduce spine outgrowth through blocking phosphorylation
of Rpt6-S120, we treated Rpt6-S120A-transfected neurons
with KN-93. Spine outgrowth in Rpt6-S120A-transfected
neurons treated with KN-93 (42% ± 8%; Figure 4B) was not
significantly different from KN-93-treated neurons (p = 0.8) or
untreated Rpt6-S120A neurons (p = 0.7; Figure 3C), suggesting
that CaMKII and the proteasome act in the same pathway to
regulate spine outgrowth. Moreover, the reduction in new spine
growth observed after KN-93 treatment was not significantly
different than that after lactacystin (p = 0.5; Figure 1C) or CPP
(p = 0.5; Figure 2G) treatment. Thus, our data suggest that CaM-
KII acts downstream of NMDA receptors to enhance local pro-
teasomal activity via phosphorylation of the Rpt6 proteasomal
subunit at serine 120.
Interaction of CaMKII with GluN2B Is Necessary for
Activity- and Proteasome- Dependent Spine Outgrowth
Because interrupting CaMKII binding to the NMDA receptor
subunit GluN2B has been shown to decrease spine density
(Gambrill and Barria, 2011), we examined whether this interac-
tion is important for activity- and proteasome-dependent spine
growth using GluN2B-L1298A/R1300Q knockin (GluN2B KI)
mice (Halt et al., 2012). Both the L1298A and R1300Q mutations
reduce GluN2B interaction with CaMKII by over 85% in vitro
(Strack et al., 2000), and these two mutations abrogate theactivity-dependent increase in NMDA receptor-CaMKII interac-
tion in vivo (Halt et al., 2012).
In order to determine whether interaction of CaMKII with
GluN2B is necessary for activity- and proteasome-dependent
spine outgrowth, we transfected hippocampal slice cultures
from WT and GluN2B KI mice with EGFP and examined the
consequences of treatment with bicuculline (30 mM) or lactacys-
tin (10 mM) on rates of spine outgrowth (Figures 4C and 4D). As
expected, we found that treatment of WT mouse neurons with
bicuculline resulted in a 50% increase in spine outgrowth
(150% ± 14%) relative to vehicle-treated WT control neurons
(100% ± 10%; p < 0.05; Figure 4D). Remarkably, treatment
with bicuculline did not alter outgrowth in GluN2B KI neurons
(93% ± 6%) relative to vehicle-treated GluN2B KI controls
(100% ± 11%; p = 0.6; Figure 4D). Conversely, treatment with
lactacystin reduced spine outgrowth in WT neurons by 69%
(31% ± 6%) relative to vehicle-treated WT controls (100% ±
6%; p < 0.001), while GluN2B KI neurons were unaffected by
lactacystin treatment (92% ± 12%) as compared to vehicle-
treated GluN2B KI controls (100% ± 21%; p = 0.8; Figure 4D).
Thus, we conclude that the interaction between CaMKII and
GluN2B is necessary for activity- and proteasome-dependent
spinogenesis.
Surprisingly, we found that baseline spine outgrowth on
GluN2B KI control neurons was not different than that on WT
control neurons (Table S1; p = 0.7). We predict that compensa-
tory mechanisms are involved, whereby GluN2B KI mice experi-
ence an increase in activity- and proteasome-independent spine
outgrowth. To further confirm this possibility, we tested the effect
of blocking NMDA receptors with CPP on spine outgrowth in WT
and GluN2B KI mice. As expected, we found that treatment with
CPP reduced spine outgrowth on neurons fromWTmice by 42%
(58% ± 9%) relative to vehicle-treated WT control neurons
(100% ± 10%, p < 0.05) but had no effect on neurons from
GluN2B KI mice (96% ± 12%) relative to vehicle-treated GluN2B
KI controls (100 ± 24, p = 0.9; Figure S4). These data support that
spine outgrowth on GluN2B KI neurons is both activity and
proteasome independent.
DISCUSSION
Pharmacological inhibition of the proteasome can lead to
presynaptic, postsynaptic, and potentially circuit-wide effects
(Bingol and Sheng, 2011; Tai and Schuman, 2008). Which site
or sites of action are relevant for activity-induced new spine
growth? We observed that expression of Rpt6-S120A in indi-
vidual neurons inhibited activity-induced spine outgrowth.
Because this genetic manipulation was carried out in sparsely
transfected neurons, and thus any nearby presynaptic neurons
were untransfected, our results demonstrate that postsynaptic
proteasomal function is necessary to facilitate new spine growth.
In addition, because global pharmacological inhibition was not
more effective at reducing spine outgrowth than overexpression
of Rpt6-S120A in individual postsynaptic cells, our data also
suggest that independent presynaptic and circuit-wide effects
do not contribute significantly to the observed reduction in new
spine growth. Finally, uncaging-induced spine outgrowth, which
is independent of presynaptic activity, was also significantlyNeuron 74, 1023–1030, June 21, 2012 ª2012 Elsevier Inc. 1027
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(A) Images of dendrites from EGFP-expressing hippocampal neurons at 7–10 DIV before and after the addition of myristoylated PKI 14–22 (20 mM), Rp-cAMPS
(5 mM), or KN-93 (30 mM) at t = 0 (black arrow). Yellow arrows indicate new spines. (B) Inhibition of PKAwith PKI 14–22 (dark gray bar; 58 spines, 7 cells; p = 0.9) or
Rp-cAMPS (light gray bar; 66 spines, 7 cells; p = 0.4) did not alter rates of spine outgrowth relative to vehicle-treated controls (black bar; 54 spines, 7 cells). In
contrast, inhibition of CaMKs with KN-93 decreased spine outgrowth (light green bar; 40 spines, 7 cells; p < 0.001) but did not further decrease spine outgrowth
in cells transfected with Rpt6-S120A (dark green bar; 34 spines, 7 cells; p = 0.6). (C) Images of dendrites from EGFP-expressing WT or GluN2B L1298A/R1300Q
knockin (GluN2B KI) mouse neurons at 8–11 DIV, before and after treatment with vehicle, bicuculline (30 mM), or lactacystin (10 mM) at t = 0 (black arrow). Yellow
arrows indicate new spines. (D) In neurons from WT mice, treatment with bicuculline increased spine outgrowth (solid blue bar; 76 spines, 5 cells; p = 0.01)
relative to vehicle-treated controls (solid black bar; 40 spines, 4 cells), while lactacystin decreased spine outgrowth (solid green bar; 16 spines, 5 cells) relative to
controls (solid black bar; 54 spines, 5 cells). In contrast, in neurons from GluN2B KI mice, neither bicuculline (open blue bar; 41 spines, 5 cells; p = 0.6) nor
lactacystin (open green bar; 42 spines, 5 cells; p = 0.8) altered spine outgrowth relative to vehicle-treated controls (open black bar; 45 spines, 5 cells). Error bars
represent SEM.
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localized postsynaptic signaling. Our results strongly support
a postsynaptic site of action for the proteasome in activity-
induced new spine outgrowth.1028 Neuron 74, 1023–1030, June 21, 2012 ª2012 Elsevier Inc.How might synaptic activity and the proteasome act together
to facilitate new spine growth? One possibility is that synaptic
activity enhances proteasome function to cause the emergence
of new spines. Alternatively, the synaptic stimulus could be the
Neuron
Proteasomal Regulation of New Spine Growthprimary cause of spine outgrowth, and normal steady-state
levels of proteasomal degradation are required for activity-
induced new spine growth. We think that the latter possibility is
unlikely because expression of Rpt6-S120A for 4 days does
not produce any noticeable effects on cell health compared to
untransfected neurons, suggesting that general proteasomal
function is not significantly disrupted. In addition, the Rpt6-
S120A mutation does not interfere with normal steady-state
levels of proteasome-mediated protein degradation in heterolo-
gous cells (Djakovic et al., 2012). Instead, because the Rpt6-
S120A mutation blocks CaMKII-mediated enhancement of pro-
teasomal degradation (Djakovic et al., 2012), our data suggest
that locally enhanced proteasomal degradation, probably
through CaMKII phosphorylation of Rpt6 at S120, is required
for activity-induced new spine growth.
How might neural activity translate to enhanced local protea-
somal degradation? Changes in neuronal activity have been
shown to alter both proteasome activity (Bingol and Schuman,
2006; Djakovic et al., 2009) and localization (Bingol and Schu-
man, 2006; Bingol et al., 2010). Although the relative contribu-
tions of changes in unit proteasome activity versus changes in
proteasome localization to facilitating new spine outgrowth are
not yet clear, our findings that spine outgrowth is reduced in
mice with impaired NMDA receptor-CaMKII interaction support
the possibility that relocation of the proteasome in response to
activity may play a role in supporting new spine growth. In these
GluN2B KI mice, activity-dependent association of CaMKII with
the NMDA receptor is abrogated without altering CaMKII-T286
autophosphorylation, indicating that stimulus-induced activation
of CaMKII is normal (Halt et al., 2012). Thus, activity-dependent
new spine growth could depend upon the local concentration of
active proteasomes rather than stimulation of global proteaso-
mal activity.
What target proteins are degraded by the proteasome in order
to stimulate new spine growth? Due to the rapid reduction in
spinogenesis observed with proteasome inhibition, we expect
that the immediate protein targets normally act to inhibit spine
outgrowth and are rapidly turned over in an activity- and protea-
some-dependent manner. Although a large number of proteins
have been shown to regulate spine morphology and dynamics,
the most promising candidates for regulating new spine out-
growth are those associated with regulation of the spine actin
cytoskeleton (Tashiro and Yuste, 2004; Tolias et al., 2011). One
promising candidate could be Ephexin5, a RhoA guanine nucle-
otide exchange factor shown to negatively regulate excitatory
synapse formation (Margolis et al., 2010). Another prime candi-
date could be Rap2, a member of the Ras family of GTPases.
Rap2 overexpression causes a reduction in dendritic spine
density (Ryu et al., 2008), suggesting that it may be a negative
regulator of spinogenesis. Both of these candidates are plausible
targets of activity-induced upregulation of proteasomal activity;
in each case, enhanced degradation would be expected to
lead to increased spine density.
Malfunction of the proteasome (Tai and Schuman, 2008) and
alterations in dendritic spine morphologies and densities (Bhatt
et al., 2009) have independently been associated with neurolog-
ical disorders resulting in mental retardation. Our data support
a direct role for the proteasome in the activity-induced spinogen-esis thought to be critical for normal brain function and for
learning and memory. Disruption of proteasome-mediated
degradation would be expected to interrupt activity-induced
spine outgrowth during experience-dependent circuit modifica-
tions, suggesting one plausible mechanism by which proteaso-
mal dysfunction may lead to neurological dysfunction.
EXPERIMENTAL PROCEDURES
Hippocampal Slice Culture and Transfection
Hippocampal slices were prepared from postnatal day (P) 5–P7 Sprague-
Dawley rats or wild-type or GluN2B KI mice (Halt et al., 2012), as described
(Stoppini et al., 1991). Genes were delivered 2–5 days (EGFP alone) or
3–4 days (EGFP and Rpt6-WT or Rpt6-S120A) prior to imaging using biolistic
gene transfer (180 PSI), as described (Woods and Zito, 2008). We coated
1.6 mm gold beads with 10 mg of EGFP (Clontech) or with 10 mg EGFP and
25 mg HA-tagged Rpt6-WT or Rpt6-S120A (Djakovic et al., 2012).
Time-Lapse Imaging and Image Analysis
EGFP-transfected pyramidal neurons (5–12 days in vitro [DIV]) were imaged at
29C in ACSF using a custom two-photon microscope (Woods et al., 2011;
Supplemental Experimental Procedures). All images shown are maximum
projections of three-dimensional (3D) stacks. Spine volumes, densities, and
turnover rates were analyzed in 3D using custom software. Because spine
addition rates can vary between cultures and experimental days, spine addi-
tion rates are reported as a percent of matched controls (calculated using all
spines gained in the three posttreatment time points). Absolute spine addition
and loss rates for all experiments are documented in Table S1.
Pharmacology
We prepared 1,0003 stocks by dissolving MG132 (A.G. Scientific) and KN-93
(Tocris) in DMSO and bicuculline (Tocris), lactacystin (EMD Biochemicals),
myristoylated PKI 14–22 amide (Tocris), Rp-cAMPS (Tocris), and CPP (Sigma)
in water. Vehicle controls were matched in identity and volume to that in which
the inhibitor was dissolved. When two drugs were applied, the vehicle con-
sisted of the sum of the vehicles for both drugs.
Two-Photon Glutamate Uncaging-Induced Spine Outgrowth
Slices were imaged at 30C in magnesium-free ACSF containing 5 mM
MNI-caged-glutamate. Image stacks were acquired immediately before and
after the uncaging stimulus, which consisted of 50 pulses (720 nm, 12 mW
at the sample) of 4 ms duration delivered at 5 Hz by parking the beam at
a point 0.5 mm from the edge of a secondary or tertiary apical dendrite. No
more than four uncaging trials were performed on the same neuron. The
success rate of de novo spine outgrowth was determined by two blind evalu-
ators. Comparison of success rate across conditions was made by Fisher’s
exact test.
Statistics
Error bars represent standard error of the mean and significance was set at
p = 0.05 (two-tailed t test, unless otherwise noted). All statistics were calcu-
lated across cells. *p < 0.05 and **p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2012.04.031.
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